Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.350
-0.060 (-2.49%)
Oct 17, 2025, 10:34 AM EDT - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $107.31 million as of October 17, 2025. Its market cap has increased by 61.43% in one year.
Market Cap
107.31M
Enterprise Value
97.34M
1-Year Change
61.43%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $107.31M, an increase of 49.52%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 110.05M | 40.94% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |